Literature DB >> 25449511

Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation.

Baigalmaa Lkhagva1, Shih-Lin Chang2, Yao-Chang Chen3, Yu-Hsun Kao4, Yung-Kuo Lin5, Cindy Tzu-Hsuan Chiu6, Shih-Ann Chen2, Yi-Jen Chen7.   

Abstract

Pulmonary veins (PVs) play a critical role in the pathophysiology of atrial fibrillation (AF). Histone deacetylases (HDACs) are vital to calcium homeostasis and AF genesis. However, the electrophysiological effects of HDAC inhibition were unclear. This study evaluated whether HDAC inhibition can regulate PV electrical activity through calcium modulation. Whole-cell patch-clamp, confocal microscopic with fluorescence, and Western blot were used to evaluate electrophysiological characteristics and Ca(2+) dynamics in isolated rabbit PV cardiomyocytes with and without MPT0E014 (a pan HDAC inhibitor), MS-275 (HDAC1 and 3 inhibitor), and MC-1568 (HDAC4 and 6 inhibitor) for 5~8h. Atrial electrical activity and induced-AF (rapid atrial pacing and acetylcholine infusion) were measured in rabbits with and without MPT0E014 (10mg/kg treated for 5 hours) in vivo. MPT0E014 (1 μM)-treated PV cardiomyocytes (n=12) had slower beating rates (2.1 ± 0.2 vs. 2.8 ± 0.1 Hz, p < 0.05) than control PV cardiomyocytes. However, control (n=11) and MPT0E014 (1 μM)-treated (n = 12) SAN cardiomyocytes had similar beating rates (3.2 ± 0.2 vs. 2.9 ± 0.3 Hz). MS-275-treated PV cardiomyocytes (n = 12, 2.3 ± 0.2 Hz), but not MC-1568-treated PV cardiomyocytes (n=14, 3.1 ± 0.3 Hz) had slower beating rates than control PV cardiomocytes. MPT0E014-treated PV cardiomyocytes (n=14) had a lower frequency (2.4 ± 0.6 vs. 0.3 ± 0.1 spark/mm/s, p < 0.05) of Ca(2+) sparks than control PV (n=17) cardiomyocytes. As compared to control, MPT0E014-treated PV cardiomyocytes had reduced Ca(2+) transient amplitudes, sodium-calcium exchanger currents, and ryanodine receptor expressions. Moreover, MPT0E014-treated rabbits had less AF and shorter AF duration than control rabbits. In conclusions, HDAC inhibition reduced PV arrhythmogenesis and AF inducibility with modulation on calcium homeostasis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Calcium homeostasis; Histone deacetylase inhibition; Pulmonary vein

Mesh:

Substances:

Year:  2014        PMID: 25449511     DOI: 10.1016/j.ijcard.2014.09.175

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Authors:  Mitsuru Seki; Ryan LaCanna; Jeffery C Powers; Christine Vrakas; Fang Liu; Remus Berretta; Geena Chacko; John Holten; Pooja Jadiya; Tao Wang; Jeffery S Arkles; Joshua M Copper; Steven R Houser; Jianhe Huang; Vickas V Patel; Fabio A Recchia
Journal:  J Pharmacol Exp Ther       Date:  2016-06-27       Impact factor: 4.030

3.  Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes.

Authors:  Patrick Lugenbiel; Katharina Govorov; Pascal Syren; Ann-Kathrin Rahm; Teresa Wieder; Maximilian Wunsch; Nadine Weiberg; Emili Manolova; Dominik Gramlich; Rasmus Rivinius; Daniel Finke; Lorenz H Lehmann; Patrick A Schweizer; Derk Frank; Fadwa A El Tahry; Claus Bruehl; Tanja Heimberger; Steffi Sandke; Tanja Weis; Patrick Most; Bastian Schmack; Arjang Ruhparwar; Matthias Karck; Norbert Frey; Hugo A Katus; Dierk Thomas
Journal:  Basic Res Cardiol       Date:  2021-02-25       Impact factor: 17.165

4.  Redox and Activation of Protein Kinase A Dysregulates Calcium Homeostasis in Pulmonary Vein Cardiomyocytes of Chronic Kidney Disease.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Ming-Hsiung Hsieh; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Am Heart Assoc       Date:  2017-07-12       Impact factor: 5.501

5.  Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Ming-Hsiung Hsieh; Yung-Kuo Lin; Cheng-Chih Chung; Ting-I Lee; Wen-Chin Tsai; Shih-Ann Chen; Yi-Jen Chen
Journal:  Oncotarget       Date:  2016-10-25

6.  Hydrogen sulphide increases pulmonary veins and atrial arrhythmogenesis with activation of protein kinase C.

Authors:  Chao-Shun Chan; Yung-Kuo Lin; Yu-Hsun Kao; Yao-Chang Chen; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Cell Mol Med       Date:  2018-04-16       Impact factor: 5.310

Review 7.  Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation.

Authors:  Dan Li; Jiali Nie; Yu Han; Li Ni
Journal:  Front Cardiovasc Med       Date:  2022-01-21

Review 8.  Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis.

Authors:  Wan-Li Cheng; Shao-Jung Li; Ting-I Lee; Ting-Wei Lee; Cheng-Chih Chung; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Biomedicines       Date:  2021-06-25

Review 9.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.